InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Richard Stephen, Director. Officer active across 2 companies, notably Anika Therapeutics, Inc.. In total, 3 reports have been published. The latest transaction was disclosed on 8 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
07,954 shares0
Common Stock
SEC:0001171843-22-004301:0·
04,172 shares0
Common Stock
SEC:0001171843-21-004429·
04,172 shares0
Common Stock
SEC:0001171843-21-004429:0·
3 of 3 declarations
About Richard Stephen
Richard Stephen is a Board Member at Anika Therapeutics, Inc. He brings valuable experience in the biopharmaceutical sector, contributing to the strategic direction of the company. His role includes overseeing operations and commitment to best governance practices.
